Connect with us

Hi, what are you looking for?

press release

THE AESTHETIC SOCIETY & AESTHETIC SURGERY EDUCATION AND – Press Release

Studying wants to understand the possible etiologies of systemic symptoms self-reported by some breast implant patients known as breast implant disease

GARDEN GROVE, CA., November 9, 2022 /PRNewswire/ — The Aesthetic Society and the Aesthetic Surgery Education and Research Foundation (ASERF) today released the results of a study dedicated to exploring the systemic symptoms self-reported by some breast implant patients, known as Breast Implant Illness . With 2,600 board-certified plastic surgeons, the Aesthetic Society is recognized as the world’s leading membership organization dedicated solely to aesthetic plastic surgery and cosmetic medicine of the face and body. ASERF is the philanthropic research and education arm of The Aesthetic Society. This study was funded entirely by a Education and Research Foundation for Aesthetic Surgery (ASERF) Scholarship awarded in 2019. There was no involvement of external sponsors in the research, data collection, data interpretation, data analysis, or writing of the manuscript. The full study will be published in a peer-reviewed medical journal Journal of Aesthetic Surgery.

Breast Implant Illness (BII) is a term used to describe a variety of symptoms experienced by patients with breast implants who have no abnormal physical or laboratory findings to explain their symptoms. This is the first prospective, blinded, controlled-group study to evaluate women with breast implant disease both qualitatively with symptom assessments and quantitatively…

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...